PARLIAMENTARY WRITTEN QUESTION
(11 December 2025)

To ask the Secretary of State for Science, Innovation and Technology, what funding the Government has allocated to support new or expanded manufacturing facilities for advanced glioblastoma treatments.

Asked by:
Lewis Cocking (Conservative)

This Government has made funds available to support UK manufacture of medicines and medical technology products, including up to £520 million to the Life Sciences Innovative Manufacturing Fund and £50 million to the pilot Life Sciences Transformational R&D Investment fund. These funds are open to applicants looking to establish, expand or improve UK based manufacturing of treatments for glioblastoma and other cancers, as well as a wider range of capabilities that improve UK health resilience.

Answered by:
()